BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22517408)

  • 1. Life years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale.
    Brodin NP; Vogelius IR; Maraldo MV; Munck af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Nilsson P; Björk-Eriksson T; Specht L; Bentzen SM
    Cancer; 2012 Nov; 118(21):5432-40. PubMed ID: 22517408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk.
    Brodin NP; Vogelius IR; Björk-Eriksson T; Munck Af Rosenschöld P; Maraldo MV; Aznar MC; Specht L; Bentzen SM
    Acta Oncol; 2014 Apr; 53(4):462-70. PubMed ID: 24274390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
    Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
    Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
    Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
    Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric craniospinal irradiation with a short partial-arc VMAT technique for medulloblastoma tumors in dosimetric comparison.
    Pollul G; Bostel T; Grossmann S; Akbaba S; Karle H; Stockinger M; Schmidberger H
    Radiat Oncol; 2020 Nov; 15(1):256. PubMed ID: 33153495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT.
    Al-Wassia RK; Ghassal NM; Naga A; Awad NA; Bahadur YA; Constantinescu C
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e405-11. PubMed ID: 26334433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of secondary cancer in pediatric medulloblastoma patients due to three-dimensional conformal radiotherapy and intensity-modulated radiotherapy.
    Sherif RS; Elshemey WM; Attalla EM
    Indian J Cancer; 2018; 55(4):372-376. PubMed ID: 30829273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
    Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
    Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-field doses from pediatric craniospinal irradiations using 3D-CRT, IMRT, helical tomotherapy and electron-based therapy.
    De Saint-Hubert M; Verellen D; Poels K; Crijns W; Magliona F; Depuydt T; Vanhavere F; Struelens L
    Phys Med Biol; 2017 Jul; 62(13):5293-5311. PubMed ID: 28398210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
    Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
    Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.
    Kahalley LS; Peterson R; Ris MD; Janzen L; Okcu MF; Grosshans DR; Ramaswamy V; Paulino AC; Hodgson D; Mahajan A; Tsang DS; Laperriere N; Whitehead WE; Dauser RC; Taylor MD; Conklin HM; Chintagumpala M; Bouffet E; Mabbott D
    J Clin Oncol; 2020 Feb; 38(5):454-461. PubMed ID: 31774710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
    Ho ESQ; Barrett SA; Mullaney LM
    Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
    Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.